Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

02/10/2020 Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC) 23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 22/01/2020 PaCIR: A tool to enhance pharmacist patient care intervention reporting 11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 20/04/2016 Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency 11/03/2016 Reporting guidelines for population pharmacokinetic analyses 04/03/2016 Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement 17/09/2014 Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology 14/08/2013 Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials

Blog archives

Latest guest blogger